title: Femoral pseudoaneurysm from drugs of abuse: ligation or reconstruction?
abstract: A plan for management of infected arterial pseudoaneurysm has evolved from our experience with 23 such aneurysms treated between 1981 and 1989 and followed for up to 66 months. Eighteen femoral artery aneurysms are the primary focus of this report. Because we were concerned about the high probability of amputation expected from acute interruption of the femoral artery, we were reluctant to limit initial management to ligation and debridement alone. However, significant complications developed in 12 patients who underwent revascularization, requiring 3 amputations and 13 secondary arterial operations in addition to debridements and skin grafts. In contrast, no amputations were required in six patients who underwent primary arterial ligation and debridement. We recommend primary ligation that controls the septic focus, removes the danger of hemorrhage, and is not accompanied by the threat of secondary arterial infection. After ligation, limb viability is assessed during surgery by presence of an audible Doppler signal at the ankle. Revascularization is considered only when absence of a Doppler signal indicates acute limb ischemia.
authors.affiliation: Section of Vascular Surgery, New Jersey Medical School, University Hospital, Newark.
authors.forename: F
authors.initials: F
authors.lastname: Padberg
authors.forename: R
authors.initials: R
authors.lastname: Hobson
authors.forename: B
authors.initials: B
authors.lastname: Lee
authors.forename: R
authors.initials: R
authors.lastname: Anderson
authors.forename: J
authors.initials: J
authors.lastname: Manno
authors.forename: G
authors.initials: G
authors.lastname: Breitbart
authors.forename: K
authors.initials: K
authors.lastname: Swan
mesh_terms: D000328:Adult; D000671:Amputation, Surgical; D000785:Aneurysm, Infected / Q000175:diagnosis / Q000209:etiology / Q000601:surgery*; D003646:Debridement; D005260:Female; D005263:Femoral Artery / Q000293:injuries / Q000601:surgery*; D005500:Follow-Up Studies; D006801:Humans; D007269:Injections, Intra-Arterial / Q000009:adverse effects; D007511:Ischemia / Q000209:etiology / Q000601:surgery; D007866:Leg / Q000098:blood supply*; D008026:Ligation; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000209:etiology / Q000601:surgery*; D019966:Substance-Related Disorders / Q000150:complications*; D016896:Treatment Outcome